Kraken IPO, M&A Deals to Reignite Crypto’s ‘Mid-Stage’ Cycle: Fund Manager The cryptocurrency market is poised for a significant evolution, moving beyond pure speculation into a new phase of institutional maturity. According to industry fund managers, catalysts like the anticipated Kraken IPO and a surge in mergers and acquisitions are set to reignite the cycle….
Kraken IPO, M&A Deals to Reignite Crypto’s ‘Mid-Stage’ Cycle: Fund Manager The cryptocurrency market is poised for a significant evolution, moving beyond pure speculation. According to industry fund managers, a wave of public listings and mergers could attract a new class of investors. The Gateway to Traditional Finance Kraken’s anticipated initial public offering (IPO) represents…
Kraken IPO, M&A Deals to Reignite Crypto’s ‘Mid-Stage’ Cycle: Fund Manager The crypto industry is on the cusp of a significant evolution, moving beyond the volatility of retail speculation. According to leading fund managers, a wave of public listings and strategic mergers is poised to attract a new class of institutional capital. The Gateway: Public…
The Year the Data Center Stepped Out of the Shadows For decades, the data center was the ultimate background actor. It was the humming, fluorescent-lit engine room of the digital age—essential, yet deliberately unseen and unremarked upon. Its concerns were the domain of IT specialists: uptime percentages, cooling efficiency, and rack densities. To the public,…
Ascletis Pharma Shares Surge on Drug Results Ascletis Pharma Inc. shares surged Tuesday, posting their biggest rally since April, after mid-stage results for its oral weight-loss drug suggested a potential best-in-class profile. Key Details The positive movement followed the release of promising mid-stage trial results for the company’s oral weight-loss treatment. Image: Road Trip with…
